283 related articles for article (PubMed ID: 15938110)
1. [Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus].
Shapiro IIa; Shabrov AV; Karev VE; Leenman EE; Kvetnoĭ IM; Tsinzerling VA; Sologub TV
Arkh Patol; 2005; 67(2):6-10. PubMed ID: 15938110
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
[TBL] [Abstract][Full Text] [Related]
3. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
[TBL] [Abstract][Full Text] [Related]
4. Increasing evidence that hepatitis B virus X gene protein and p53 protein may interact in the pathogenesis of hepatocellular carcinoma.
Kew MC
Hepatology; 1997 Apr; 25(4):1037-8. PubMed ID: 9096618
[No Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
6. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.
Dewantoro O; Gani RA; Akbar N
Acta Med Indones; 2006; 38(3):154-9. PubMed ID: 16953033
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
Kasai Y; Takeda S; Takagi H
Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
[TBL] [Abstract][Full Text] [Related]
10. Functional inactivation but not structural mutation of p53 causes liver cancer.
Ueda H; Ullrich SJ; Gangemi JD; Kappel CA; Ngo L; Feitelson MA; Jay G
Nat Genet; 1995 Jan; 9(1):41-7. PubMed ID: 7704023
[TBL] [Abstract][Full Text] [Related]
11. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
12. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
13. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
14. [The determination of the viral markers of the hepatitis B virus and protein p53 in liver biopsy samples].
Lörinczi L; Székely E
Bacteriol Virusol Parazitol Epidemiol; 1998; 43(3):161-6. PubMed ID: 9932005
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
16. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and hepatocellular carcinoma: a possible role for the viral transactivators.
Levrero M; Balsano C; Avantaggiati ML; Natoli G; De Marzio E; Will H
Ital J Gastroenterol; 1991 Dec; 23(9):576-83. PubMed ID: 1662093
[TBL] [Abstract][Full Text] [Related]
18. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
Lin CL; Kao JH
J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
